source
- Novo signs development deal with Swedish biotech Nanexa to license long-acting delivery technologyNovo Nordisk has entered a new development agreement with the Swedish biotech Nanexa. Under the pact, Nanexa will license its long-acting drug delivery platform to Novo, expanding the larger compa…
- Experts say measles death counts are muddled by 'with' vs 'of' debatePublic health scientists note that Pennsylvania reported two measles‑related deaths in August, but the county coroner described one infant as having died "with" measles rather than "from" the disea…